Combination therapy will be the future for the antiviral treatment of chronic hepatitis B

( views:247, downloads:0 )
Author:
LIU Ke-zhou(State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310003,China)
Journal Title:
Chinese Journal of Clinical Infectious Diseases
Issue:
Volume 05, Issue 03, 2012
DOI:
10.3760/cma.j.issn.1674-2397.2012.03.001
Key Word:
Chronic hepatitis B;Antiviral agents;Combination therapy

Abstract:

  • [1]中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版).中华临床感染病杂志,2011,4(1):1-13.
  • [2]许蓓,徐国光,郭清,等.拉米夫定对慢性乙型肝炎伴重度肝纤维化患者的长期应用疗效——NUCB 4006十年随访研究.中华传染病杂志,2010,28(11):656-661.
  • [3]核苷(酸)类药物联合治疗慢性乙型肝炎专家建议.中华临床感染病杂志,2011,4(2):65-68.
  • [4]European Association for the Study of the Liver.EASL Clinical Practice Guidelines:Management of chronic hepatitis B virus infection.J Hepatol,2012.[Epub ahead of print]
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn